MELODY OETH: Open Payments
NPI 1104148634 · MOUNT VERNON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 50 payments from 16 companies in 2025. Trend: 2023 $695 · 2024 $748 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $124 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Amgen Inc. | 4 | $69 |
| Lundbeck LLC | 3 | $57 |
| Eisai Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Novo Nordisk Inc | 3 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: QULIPTA, CAPLYTA, REXULTI, TRELEGY ELLIPTA, OTEZLA, Leqembi, UBRELVY, XIFAXAN.
Industry payments across IN — which companies pay providers there.
